BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9164647)

  • 1. Regulation of matrilysin in the rat uterus.
    Woessner JF
    Biochem Cell Biol; 1996; 74(6):777-84. PubMed ID: 9164647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of rat uterine matrilysin and its cDNA. Relationship to human pump-1 and activation of procollagenases.
    Abramson SR; Conner GE; Nagase H; Neuhaus I; Woessner JF
    J Biol Chem; 1995 Jul; 270(27):16016-22. PubMed ID: 7608162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7).
    Yu WH; Woessner JF
    J Biol Chem; 2000 Feb; 275(6):4183-91. PubMed ID: 10660581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice.
    Rudolph-Owen LA; Hulboy DL; Wilson CL; Mudgett J; Matrisian LM
    Endocrinology; 1997 Nov; 138(11):4902-11. PubMed ID: 9348221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Messenger ribonucleic acid levels of collagenase (MMP-13) and matrilysin (MMP-7) in virgin, pregnant, and postpartum uterus and cervix of rat.
    Wolf K; Sandner P; Kurtz A; Moll W
    Endocrinology; 1996 Dec; 137(12):5429-34. PubMed ID: 8940367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus.
    Balbín M; Fueyo A; Knäuper V; Pendás AM; López JM; Jiménez MG; Murphy G; López-Otín C
    J Biol Chem; 1998 Sep; 273(37):23959-68. PubMed ID: 9727011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution.
    Manase K; Endo T; Chida M; Nagasawa K; Honnma H; Yamazaki K; Kitajima Y; Goto T; Kanaya M; Hayashi T; Mitaka T; Saito T
    Reprod Biol Endocrinol; 2006 Jun; 4():32. PubMed ID: 16740171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
    von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrilysin activity in the rat uterus during the oestrous cycle and implantation.
    Feng J; Woessner JF; Zhu C
    J Reprod Fertil; 1998 Nov; 114(2):347-50. PubMed ID: 10070364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrilysin-inhibitor complexes: common themes among metalloproteases.
    Browner MF; Smith WW; Castelhano AL
    Biochemistry; 1995 May; 34(20):6602-10. PubMed ID: 7756291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrilysin expression in the involuting rat ventral prostate.
    Powell WC; Domann FE; Mitchen JM; Matrisian LM; Nagle RB; Bowden GT
    Prostate; 1996 Sep; 29(3):159-68. PubMed ID: 8827084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases.
    Crabbe T; Willenbrock F; Eaton D; Hynds P; Carne AF; Murphy G; Docherty AJ
    Biochemistry; 1992 Sep; 31(36):8500-7. PubMed ID: 1390635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
    Uría JA; López-Otín C
    Cancer Res; 2000 Sep; 60(17):4745-51. PubMed ID: 10987280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small matrix metalloproteinase of the rat uterus.
    Woessner JF
    Matrix Suppl; 1992; 1():58-63. PubMed ID: 1480088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin.
    Sires UI; Murphy G; Baragi VM; Fliszar CJ; Welgus HG; Senior RM
    Biochem Biophys Res Commun; 1994 Oct; 204(2):613-20. PubMed ID: 7980522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3.
    Mochizuki S; Shimoda M; Shiomi T; Fujii Y; Okada Y
    Biochem Biophys Res Commun; 2004 Feb; 315(1):79-84. PubMed ID: 15013428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
    Reynolds JJ; Meikle MC
    J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions.
    Wilson CL; Matrisian LM
    Int J Biochem Cell Biol; 1996 Feb; 28(2):123-36. PubMed ID: 8729000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites.
    Sires UI; Griffin GL; Broekelmann TJ; Mecham RP; Murphy G; Chung AE; Welgus HG; Senior RM
    J Biol Chem; 1993 Jan; 268(3):2069-74. PubMed ID: 8380588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
    Clements JM; Cossins JA; Wells GM; Corkill DJ; Helfrich K; Wood LM; Pigott R; Stabler G; Ward GA; Gearing AJ; Miller KM
    J Neuroimmunol; 1997 Apr; 74(1-2):85-94. PubMed ID: 9119983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.